0001415889-24-012911.txt : 20240510
0001415889-24-012911.hdr.sgml : 20240510
20240510180436
ACCESSION NUMBER: 0001415889-24-012911
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240508
FILED AS OF DATE: 20240510
DATE AS OF CHANGE: 20240510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grant Jeremy T
CENTRAL INDEX KEY: 0002004368
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36033
FILM NUMBER: 24936339
MAIL ADDRESS:
STREET 1: C/O OLSHAN FROME WOLOSKY LLP
STREET 2: 1325 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theravance Biopharma, Inc.
CENTRAL INDEX KEY: 0001583107
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
BUSINESS PHONE: 650-808-6000
MAIL ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
4
1
form4-05102024_100529.xml
X0508
4
2024-05-08
0001583107
Theravance Biopharma, Inc.
TBPH
0002004368
Grant Jeremy T
C/O THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BLVD
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
0
Ordinary Shares
2024-05-08
4
A
0
10537
0
A
22305
D
Share Option (Right to Buy)
9.49
2024-05-08
4
A
0
23576
0
A
2034-05-07
Ordinary Shares
23576
23576
D
This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.
/s/ Brett A. Grimaud, Attorney-in-Fact
2024-05-10